CHEMOTHERAPY FOR ADVANCED NON–SMALL CELL LUNG CANCER

This publication has 68 references indexed in Scilit:

• Polychemotherapy in advanced non small cell lung cancer: a meta-analysis
  The Lancet, 1993
• Confirmatory activity of gemcitabine in non small cell lung cancer (NSCLC)
  European Journal Of Cancer, 1993
• A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma
  Cancer, 1992
• Combined Chemotherapy and Radiotherapy versus Best Supportive Care in the Treatment of Inoperable Non-Small-Cell Lung Cancer
  Oncology, 1992
• Long term survival analysis of stage III & IV non-small cell lung cancer patients (Pts) treated with edatrexate (ETX, 10-Edam): MG Kris, RJ Gralla, LM Potanovich, LD Marks, KMW Pisters, TA Terzakis, RT Heelan. Memorial Sloan-Kettering Cancer Center New York, NY & Ciba-Geigy Inc., Summit, NJ, USA
  Lung Cancer, 1991
• Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B
  Cancer, 1991
• Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm
  Cancer, 1990
• Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC. Results of a randomized prospective study
  Cancer, 1989
• MACC chemotherapy for adenocarcinoma and epidermoid carcinoma of the lung.Low response rate in a cooperative group study
  Cancer, 1979
• MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer
  Cancer, 1979